| scholarly article | Q13442814 |
| P2093 | author name string | Vincent G Brichard | |
| Quentin Godechal | |||
| P2860 | cites work | Safety, activity, and immune correlates of anti-PD-1 antibody in cancer | Q24633070 |
| Structure, chromosomal localization, and expression of 12 genes of the MAGE family | Q28238754 | ||
| Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma | Q34743450 | ||
| Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy | Q36637039 | ||
| Human cancer regression antigens | Q38097199 | ||
| Characterization of preexisting MAGE-A3-specific CD4+ T cells in cancer patients and healthy individuals and their activation by protein vaccination | Q39802886 | ||
| Adjuvant MAGE-A3 immunotherapy in resected non-small-cell lung cancer: phase II randomized study results. | Q50954464 | ||
| Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy. | Q50954469 | ||
| P433 | issue | 10 | |
| P921 | main subject | immunotherapy | Q1427096 |
| P304 | page(s) | e25995 | |
| P577 | publication date | 2013-09-12 | |
| P1433 | published in | OncoImmunology | Q18026500 |
| P1476 | title | MAGE-A3-specific anticancer immunotherapy in the clinical practice | |
| P478 | volume | 2 |
| Q90777008 | Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia |
| Q34532807 | CD8+ TIL recruitment may revert the association of MAGE A3 with aggressive features in thyroid tumors |
| Q33599094 | Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer |
| Q37685379 | MAGE-A Antigens and Cancer Immunotherapy |
| Q88947300 | Targeted photodynamic therapy of cancer using a novel gallium (III) tris (ethoxycarbonyl) corrole conjugated-mAb directed against cancer/testis antigens 83 |
| Q28067674 | Trends and advances in tumor immunology and lung cancer immunotherapy |
| Q28072347 | Trial Watch-Oncolytic viruses and cancer therapy |
| Q33878578 | Trial Watch: Toll-like receptor agonists in oncological indications |
Search more.